search
Back to results

Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy (RELEASE)

Primary Purpose

Asthma

Status
Completed
Phase
Phase 3
Locations
United Kingdom
Study Type
Interventional
Intervention
Budesonide/formoterol
Symbicort® Turbohaler®
Sponsored by
AstraZeneca
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Asthma focused on measuring Respiratory Tract Diseases, Bronchial Diseases, Anti-asthmatic agents, Anti-asthmatic drugs, Bronchodilators

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Aged over 18 Confirmed diagnosis of mild to moderate asthma by doctor Currently receiving inhaled corticoid-steroid medicine for treatment of asthma and requiring a review of current asthma treatment Exclusion Criteria: Women who are pregnant, breast-feeding, or planning pregnancy Patients with a history of chronic obstructive pulmonary disease Patients using any beta blocker therapy Patients receiving steroid tablets or steroid injections

Sites / Locations

  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site
  • Research Site

Outcomes

Primary Outcome Measures

In a real life setting, to compare Symbicort® Single Inhaler Therapy with a patient's previous therapy (including low dose ICS), by assessment of the changes in the Asthma Control Questionnaire score in uncontrolled asthmatic patients.

Secondary Outcome Measures

Change in forced expiratory volume in one second (FEV1)
Change in peak expiratory flow (PEF)
Patient Reported Outcomes: AQLQ(S), SATQ, RCP-3 scores

Full Information

First Posted
April 27, 2006
Last Updated
March 16, 2009
Sponsor
AstraZeneca
search

1. Study Identification

Unique Protocol Identification Number
NCT00319306
Brief Title
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
Acronym
RELEASE
Official Title
Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy
Study Type
Interventional

2. Study Status

Record Verification Date
March 2009
Overall Recruitment Status
Completed
Study Start Date
September 2005 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2006 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
AstraZeneca

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to determine whether patients with asthma are better able to manage and control their symptoms by using one inhaler daily that both prevents as well as treats the symptoms of an asthma exacerbation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
Keywords
Respiratory Tract Diseases, Bronchial Diseases, Anti-asthmatic agents, Anti-asthmatic drugs, Bronchodilators

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
550 (false)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Budesonide/formoterol
Intervention Type
Device
Intervention Name(s)
Symbicort® Turbohaler®
Primary Outcome Measure Information:
Title
In a real life setting, to compare Symbicort® Single Inhaler Therapy with a patient's previous therapy (including low dose ICS), by assessment of the changes in the Asthma Control Questionnaire score in uncontrolled asthmatic patients.
Secondary Outcome Measure Information:
Title
Change in forced expiratory volume in one second (FEV1)
Title
Change in peak expiratory flow (PEF)
Title
Patient Reported Outcomes: AQLQ(S), SATQ, RCP-3 scores

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Aged over 18 Confirmed diagnosis of mild to moderate asthma by doctor Currently receiving inhaled corticoid-steroid medicine for treatment of asthma and requiring a review of current asthma treatment Exclusion Criteria: Women who are pregnant, breast-feeding, or planning pregnancy Patients with a history of chronic obstructive pulmonary disease Patients using any beta blocker therapy Patients receiving steroid tablets or steroid injections
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Iain Small, MD
Organizational Affiliation
General Practitioner
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
AstraZeneca UK Medical Director, MD
Organizational Affiliation
AstraZeneca
Official's Role
Study Director
Facility Information:
Facility Name
Research Site
City
Fowey
State/Province
Cornwall
Country
United Kingdom
Facility Name
Research Site
City
Hove
State/Province
East Sussex
Country
United Kingdom
Facility Name
Research Site
City
Ilford
State/Province
Essex
Country
United Kingdom
Facility Name
Research Site
City
Glenrothes
State/Province
Fife
Country
United Kingdom
Facility Name
Research Site
City
Dartford
State/Province
Kent
Country
United Kingdom
Facility Name
Research Site
City
Airdrie
State/Province
Lanarkshire
Country
United Kingdom
Facility Name
Research Site
City
Hamilton
State/Province
Lanarkshire
Country
United Kingdom
Facility Name
Research Site
City
Doncaster
State/Province
North Yorkshire
Country
United Kingdom
Facility Name
Research Site
City
Cookstown
State/Province
Northern Ireland
Country
United Kingdom
Facility Name
Research Site
City
Downpatrick
State/Province
Northern Ireland
Country
United Kingdom
Facility Name
Research Site
City
Barry
State/Province
South Glamorgan
Country
United Kingdom
Facility Name
Research Site
City
Chase Terrace
State/Province
Staffordshire
Country
United Kingdom
Facility Name
Research Site
City
East Horsley
State/Province
Surrey
Country
United Kingdom
Facility Name
Research Site
City
Crawley
State/Province
West Sussex
Country
United Kingdom
Facility Name
Research Site
City
Box
State/Province
Wiltshire
Country
United Kingdom
Facility Name
Research Site
City
Bradford-On-Avon
State/Province
Wiltshire
Country
United Kingdom
Facility Name
Research Site
City
Ashford
Country
United Kingdom
Facility Name
Research Site
City
Atherstone
Country
United Kingdom
Facility Name
Research Site
City
Ayrshire
Country
United Kingdom
Facility Name
Research Site
City
Bath
Country
United Kingdom
Facility Name
Research Site
City
Blackpool
Country
United Kingdom
Facility Name
Research Site
City
Bolton
Country
United Kingdom
Facility Name
Research Site
City
Cardiff
Country
United Kingdom
Facility Name
Research Site
City
Carrickfergus
Country
United Kingdom
Facility Name
Research Site
City
Cheshire
Country
United Kingdom
Facility Name
Research Site
City
Chesterfield
Country
United Kingdom
Facility Name
Research Site
City
Coventry
Country
United Kingdom
Facility Name
Research Site
City
Dundee
Country
United Kingdom
Facility Name
Research Site
City
Ellesmere Port
Country
United Kingdom
Facility Name
Research Site
City
Fife
Country
United Kingdom
Facility Name
Research Site
City
Glasgow
Country
United Kingdom
Facility Name
Research Site
City
Harrow
Country
United Kingdom
Facility Name
Research Site
City
Larne
Country
United Kingdom
Facility Name
Research Site
City
Leeds
Country
United Kingdom
Facility Name
Research Site
City
Middlesborough
Country
United Kingdom
Facility Name
Research Site
City
Newcastle
Country
United Kingdom
Facility Name
Research Site
City
Newtownabbey
Country
United Kingdom
Facility Name
Research Site
City
Peterhead
Country
United Kingdom
Facility Name
Research Site
City
Pontypridd
Country
United Kingdom
Facility Name
Research Site
City
Reading
Country
United Kingdom
Facility Name
Research Site
City
Rugby
Country
United Kingdom
Facility Name
Research Site
City
Rutherglen
Country
United Kingdom
Facility Name
Research Site
City
Sandy
Country
United Kingdom
Facility Name
Research Site
City
Sheffield
Country
United Kingdom
Facility Name
Research Site
City
Stafford
Country
United Kingdom
Facility Name
Research Site
City
Stevenage
Country
United Kingdom
Facility Name
Research Site
City
Stockport
Country
United Kingdom
Facility Name
Research Site
City
Sunbury on Thames
Country
United Kingdom
Facility Name
Research Site
City
Sutton Coldfield
Country
United Kingdom
Facility Name
Research Site
City
Tilehurst
Country
United Kingdom
Facility Name
Research Site
City
Tonbridge
Country
United Kingdom
Facility Name
Research Site
City
Trowbridge
Country
United Kingdom
Facility Name
Research Site
City
Vale of Glamorgan
Country
United Kingdom
Facility Name
Research Site
City
Warminster
Country
United Kingdom
Facility Name
Research Site
City
Watford
Country
United Kingdom
Facility Name
Research Site
City
Wells next the Sea
Country
United Kingdom
Facility Name
Research Site
City
Westbury
Country
United Kingdom
Facility Name
Research Site
City
Woking
Country
United Kingdom
Facility Name
Research Site
City
Yaxley
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

Real Life Effectiveness in Asthma of Symbicort Single Inhaler Therapy

We'll reach out to this number within 24 hrs